𝔖 Bobbio Scriptorium

✦ LIBER ✦

1206 Phase I study of Pazopanib (PAZ) in Hepatocellular Carcinoma (HCC): evaluation of clinical activity, Pharmacokinetics (PK), and Dynamic Contrast Enhanced MRI (DCE-MRI)

✍ Scribed by C.C. Yau; P. Chen; C. Curtis; P. Murphy; G. Parker; A. Suttle; T. Arumugham; J. Hodge; M. Dar; R. Poon

Book ID: 119600179
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 50 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(09)70418-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1203 Pharmacokinetic and pharmacodynamic

1203 Pharmacokinetic and pharmacodynamic Phase I trial of ARQ 197 incorporating dynamic contrast-enhanced (DCE) and diffusion weighted (DW) magnetic resonance imaging (MRI) studies investigating the antiangiogenic and antitumor activity of selective c-Met inhibition

✍ T.A. Yap; M.P. Lolkema; N. Tunariu; D.S.W. Tan; A.T. Brunetto; M. Germuska; E. G 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Changes in Tumor Blood Flow as Measured

Changes in Tumor Blood Flow as Measured by Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) May Predict Activity of Single Agent Bevacizumab in Recurrent Epithelial Ovarian (EOC) and Primary Peritoneal Cancer (PPC) Patients: An exploratory analysis of a Gynecologic Oncology Group Phase II study

✍ Dana M. Chase; Michael W. Sill; Bradley J. Monk; Mark D. Chambers; Kathleen M. D 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 842 KB